Cost-effectiveness of Human Papillomavirus Vaccination in the United States

Cost-effectiveness of Human Papillomavirus Vaccination in the United States

We describe a simplified model, based on the current economic and health effects of human papillomavirus (HPV), to estimate the cost-effectiveness of HPV vaccination of 12-year-old girls in the United States. Under base-case parameter values, the estimated cost per quality-adjusted life year gained...

Full description

Bibliographic Details
Main Authors: Harrell W. Chesson, Donatus U. Ekwueme, Mona Saraiya, Lauri E. Markowitz
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2008-02-01
Series:Emerging Infectious Diseases
Subjects:
human papillomavirus
vaccine
cost-effectiveness
research
United States
Online Access:https://wwwnc.cdc.gov/eid/article/14/2/07-0499_article

Similar Items

Similar Items